Logo image of ALLEX.PA

LEXIBOOK LINGUISTIC ELECTRON (ALLEX.PA) Stock Fundamental Analysis

EPA:ALLEX - FR0000033599 - Common Stock

5.44 EUR
-0.02 (-0.37%)
Last: 9/3/2025, 7:00:00 PM
Fundamental Rating

8

We assign a fundamental rating of 8 out of 10 to ALLEX. ALLEX was compared to 34 industry peers in the Household Durables industry. ALLEX gets an excellent profitability rating and is at the same time showing great financial health properties. ALLEX has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! These ratings would make ALLEX suitable for value and growth and quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year ALLEX was profitable.
ALLEX had a positive operating cash flow in the past year.
Each year in the past 5 years ALLEX has been profitable.
ALLEX had a positive operating cash flow in 4 of the past 5 years.
ALLEX.PA Yearly Net Income VS EBIT VS OCF VS FCFALLEX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M

1.2 Ratios

ALLEX's Return On Assets of 16.65% is amongst the best of the industry. ALLEX outperforms 97.06% of its industry peers.
ALLEX has a better Return On Equity (30.21%) than 91.18% of its industry peers.
With an excellent Return On Invested Capital value of 25.33%, ALLEX belongs to the best of the industry, outperforming 94.12% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ALLEX is significantly above the industry average of 10.55%.
The 3 year average ROIC (23.84%) for ALLEX is below the current ROIC(25.33%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 16.65%
ROE 30.21%
ROIC 25.33%
ROA(3y)13.67%
ROA(5y)12.75%
ROE(3y)28.35%
ROE(5y)31.45%
ROIC(3y)23.84%
ROIC(5y)24.08%
ALLEX.PA Yearly ROA, ROE, ROICALLEX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

With an excellent Profit Margin value of 9.96%, ALLEX belongs to the best of the industry, outperforming 88.24% of the companies in the same industry.
ALLEX's Profit Margin has improved in the last couple of years.
ALLEX has a Operating Margin of 10.94%. This is amongst the best in the industry. ALLEX outperforms 82.35% of its industry peers.
ALLEX's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 21.26%, ALLEX is doing worse than 76.47% of the companies in the same industry.
ALLEX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.94%
PM (TTM) 9.96%
GM 21.26%
OM growth 3Y4.51%
OM growth 5Y85.85%
PM growth 3Y6.37%
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y3.56%
ALLEX.PA Yearly Profit, Operating, Gross MarginsALLEX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ALLEX is creating value.
The number of shares outstanding for ALLEX remains at a similar level compared to 1 year ago.
The number of shares outstanding for ALLEX remains at a similar level compared to 5 years ago.
The debt/assets ratio for ALLEX has been reduced compared to a year ago.
ALLEX.PA Yearly Shares OutstandingALLEX.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
ALLEX.PA Yearly Total Debt VS Total AssetsALLEX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

ALLEX has an Altman-Z score of 4.66. This indicates that ALLEX is financially healthy and has little risk of bankruptcy at the moment.
ALLEX has a better Altman-Z score (4.66) than 91.18% of its industry peers.
The Debt to FCF ratio of ALLEX is 1.13, which is an excellent value as it means it would take ALLEX, only 1.13 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.13, ALLEX belongs to the top of the industry, outperforming 97.06% of the companies in the same industry.
A Debt/Equity ratio of 0.10 indicates that ALLEX is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.10, ALLEX belongs to the best of the industry, outperforming 82.35% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.13
Altman-Z 4.66
ROIC/WACC3.43
WACC7.39%
ALLEX.PA Yearly LT Debt VS Equity VS FCFALLEX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 2.55 indicates that ALLEX has no problem at all paying its short term obligations.
ALLEX has a Current ratio of 2.55. This is in the better half of the industry: ALLEX outperforms 76.47% of its industry peers.
A Quick Ratio of 1.51 indicates that ALLEX should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.51, ALLEX belongs to the top of the industry, outperforming 85.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.55
Quick Ratio 1.51
ALLEX.PA Yearly Current Assets VS Current LiabilitesALLEX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

7

3. Growth

3.1 Past

ALLEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 47.48%, which is quite impressive.
Measured over the past years, ALLEX shows a very strong growth in Earnings Per Share. The EPS has been growing by 25.32% on average per year.
ALLEX shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.25%.
The Revenue has been growing by 26.11% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)47.48%
EPS 3Y25.32%
EPS 5YN/A
EPS Q2Q%159.9%
Revenue 1Y (TTM)26.25%
Revenue growth 3Y17.82%
Revenue growth 5Y26.11%
Sales Q2Q%35.61%

3.2 Future

The Earnings Per Share is expected to grow by 11.61% on average over the next years. This is quite good.
ALLEX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.00% yearly.
EPS Next Y10.53%
EPS Next 2Y11.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.88%
Revenue Next 2Y5%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALLEX.PA Yearly Revenue VS EstimatesALLEX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ALLEX.PA Yearly EPS VS EstimatesALLEX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8

9

4. Valuation

4.1 Price/Earnings Ratio

ALLEX is valuated cheaply with a Price/Earnings ratio of 5.73.
ALLEX's Price/Earnings ratio is rather cheap when compared to the industry. ALLEX is cheaper than 91.18% of the companies in the same industry.
When comparing the Price/Earnings ratio of ALLEX to the average of the S&P500 Index (26.84), we can say ALLEX is valued rather cheaply.
With a Price/Forward Earnings ratio of 8.38, the valuation of ALLEX can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALLEX indicates a somewhat cheap valuation: ALLEX is cheaper than 76.47% of the companies listed in the same industry.
ALLEX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.48.
Industry RankSector Rank
PE 5.73
Fwd PE 8.38
ALLEX.PA Price Earnings VS Forward Price EarningsALLEX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

85.29% of the companies in the same industry are more expensive than ALLEX, based on the Enterprise Value to EBITDA ratio.
85.29% of the companies in the same industry are more expensive than ALLEX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.62
EV/EBITDA 3.85
ALLEX.PA Per share dataALLEX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

ALLEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALLEX has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.54
PEG (5Y)N/A
EPS Next 2Y11.61%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ALLEX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LEXIBOOK LINGUISTIC ELECTRON

EPA:ALLEX (9/3/2025, 7:00:00 PM)

5.44

-0.02 (-0.37%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)08-17 2025-08-17
Earnings (Next)11-30 2025-11-30
Inst Owners15.06%
Inst Owner ChangeN/A
Ins Owners47.03%
Ins Owner ChangeN/A
Market Cap42.21M
Analysts86.67
Price Target6.12 (12.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 5.73
Fwd PE 8.38
P/S 0.57
P/FCF 7.62
P/OCF 7.07
P/B 1.73
P/tB 1.77
EV/EBITDA 3.85
EPS(TTM)0.95
EY17.46%
EPS(NY)0.65
Fwd EY11.93%
FCF(TTM)0.71
FCFY13.12%
OCF(TTM)0.77
OCFY14.13%
SpS9.54
BVpS3.14
TBVpS3.08
PEG (NY)0.54
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 16.65%
ROE 30.21%
ROCE 29.02%
ROIC 25.33%
ROICexc 46.06%
ROICexgc 47.69%
OM 10.94%
PM (TTM) 9.96%
GM 21.26%
FCFM 7.48%
ROA(3y)13.67%
ROA(5y)12.75%
ROE(3y)28.35%
ROE(5y)31.45%
ROIC(3y)23.84%
ROIC(5y)24.08%
ROICexc(3y)37.71%
ROICexc(5y)36.06%
ROICexgc(3y)40.92%
ROICexgc(5y)39.52%
ROCE(3y)27.3%
ROCE(5y)28.24%
ROICexcg growth 3Y10.39%
ROICexcg growth 5Y89.81%
ROICexc growth 3Y10.43%
ROICexc growth 5Y102.3%
OM growth 3Y4.51%
OM growth 5Y85.85%
PM growth 3Y6.37%
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y3.56%
F-Score5
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.13
Debt/EBITDA 0.27
Cap/Depr 35.7%
Cap/Sales 0.58%
Interest Coverage 24.63
Cash Conversion 64.16%
Profit Quality 75.12%
Current Ratio 2.55
Quick Ratio 1.51
Altman-Z 4.66
F-Score5
WACC7.39%
ROIC/WACC3.43
Cap/Depr(3y)102.09%
Cap/Depr(5y)66.24%
Cap/Sales(3y)2.14%
Cap/Sales(5y)1.43%
Profit Quality(3y)89.46%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.48%
EPS 3Y25.32%
EPS 5YN/A
EPS Q2Q%159.9%
EPS Next Y10.53%
EPS Next 2Y11.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.25%
Revenue growth 3Y17.82%
Revenue growth 5Y26.11%
Sales Q2Q%35.61%
Revenue Next Year4.88%
Revenue Next 2Y5%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y36.08%
EBIT growth 3Y23.14%
EBIT growth 5Y134.38%
EBIT Next Year53.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-37.88%
FCF growth 3YN/A
FCF growth 5Y11.56%
OCF growth 1Y-41.07%
OCF growth 3YN/A
OCF growth 5Y11.83%